KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cost of Revenue: 2013-2015

Historic Cost of Revenue for Biocryst Pharmaceuticals (BCRX) over the last 2 years, with Sep 2015 value amounting to $1.3 million.

  • Biocryst Pharmaceuticals' Cost of Revenue was N/A to $1.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $121,000 for FY2014, which is 23.47% up from last year.
  • Biocryst Pharmaceuticals' Cost of Revenue amounted to $1.3 million in Q3 2015, which was up 204.52% from $442,000 recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Cost of Revenue ranged from a high of $1.3 million in Q3 2015 and a low of $5,000 during Q2 2014.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Cost of Revenue value was $66,500 (recorded in 2014), while the average stood at $257,875.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Cost of Revenue crashed by 93.51% in 2014 and then spiked by 8,740.00% in 2015.
  • Over the past 3 years, Biocryst Pharmaceuticals' Cost of Revenue (Quarterly) stood at $17,000 in 2013, then soared by 152.94% to $43,000 in 2014, then soared by 8,740.00% to $1.3 million in 2015.
  • Its Cost of Revenue stands at $1.3 million for Q3 2015, versus $442,000 for Q2 2015 and $60,000 for Q1 2015.